» Articles » PMID: 33568517

Cell Type-specific MicroRNA Therapies for Myocardial Infarction

Overview
Journal Sci Transl Med
Date 2021 Feb 11
PMID 33568517
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Current interventions fail to recover injured myocardium after infarction and prompt the need for development of cardioprotective strategies. Of increasing interest is the therapeutic use of microRNAs to control gene expression through specific targeting of mRNAs. In this Review, we discuss current microRNA-based therapeutic strategies, describing the outcomes and limitations of key microRNAs with a focus on target cell types and molecular pathways. Last, we offer a perspective on the outlook of microRNA therapies for myocardial infarction, highlighting the outstanding challenges and emerging strategies.

Citing Articles

miRNA-541-5p regulates myocardial ischemia-reperfusion injury by targeting ferroptosis.

Zhao Z, Li B, Cheng D, Leng Y J Cardiothorac Surg. 2025; 20(1):63.

PMID: 39815273 PMC: 11734549. DOI: 10.1186/s13019-024-03260-2.


Spatiotemporal control of neutrophil fate to tune inflammation and repair for myocardial infarction therapy.

Kim C, Kim H, Sim W, Jung M, Hong J, Moon S Nat Commun. 2024; 15(1):8481.

PMID: 39353987 PMC: 11445496. DOI: 10.1038/s41467-024-52812-6.


Circular RNA in Cardiovascular Diseases: Biogenesis, Function and Application.

Mei S, Ma X, Zhou L, Wuyun Q, Cai Z, Yan J Biomolecules. 2024; 14(8).

PMID: 39199340 PMC: 11352787. DOI: 10.3390/biom14080952.


A 2-decade bibliometric analysis of epigenetics of cardiovascular disease: from past to present.

Mao Y, Zhao K, Chen N, Fu Q, Zhou Y, Kong C Clin Epigenetics. 2023; 15(1):184.

PMID: 38007493 PMC: 10676610. DOI: 10.1186/s13148-023-01603-9.


MicroRNA delivery based on nanoparticles of cardiovascular diseases.

Wang N, Chen C, Ren J, Dai D Mol Cell Biochem. 2023; 479(8):1909-1923.

PMID: 37542599 DOI: 10.1007/s11010-023-04821-0.


References
1.
Hunt S . Taking heart--cardiac transplantation past, present, and future. N Engl J Med. 2006; 355(3):231-5. DOI: 10.1056/NEJMp068048. View

2.
Li C, Li J, Xue K, Zhang J, Wang C, Zhang Q . MicroRNA-143-3p promotes human cardiac fibrosis via targeting sprouty3 after myocardial infarction. J Mol Cell Cardiol. 2019; 129:281-292. DOI: 10.1016/j.yjmcc.2019.03.005. View

3.
Wang X, Morelli M, Matarese A, Sardu C, Santulli G . Cardiomyocyte-derived exosomal microRNA-92a mediates post-ischemic myofibroblast activation both in vitro and ex vivo. ESC Heart Fail. 2020; 7(1):284-288. PMC: 7083461. DOI: 10.1002/ehf2.12584. View

4.
Gong L, Xu H, Guo G, Zhang T, Shi J, Chang C . Long Non-Coding RNA H19 Protects H9c2 Cells against Hypoxia-Induced Injury by Targeting MicroRNA-139. Cell Physiol Biochem. 2017; 44(3):857-869. DOI: 10.1159/000485354. View

5.
Wei K, Serpooshan V, Hurtado C, Diez-Cunado M, Zhao M, Maruyama S . Epicardial FSTL1 reconstitution regenerates the adult mammalian heart. Nature. 2015; 525(7570):479-85. PMC: 4762253. DOI: 10.1038/nature15372. View